Collplant Holdings (CLGN) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
CollPlant Holdings and Stratasys have announced the start of a pre-clinical study for 3D printed, regenerative breast implants aimed at a $3 billion market. These implants are designed to promote natural tissue growth and degrade over time, potentially revolutionizing reconstructive and aesthetic breast procedures. The collaboration combines CollPlant’s rhCollagen-based bioinks with Stratasys’ advanced printing technology.
For further insights into CLGN stock, check out TipRanks’ Stock Analysis page.
